Specific depletion of preformed IgM natural antibodies by administration of anti-mu monoclonal antibody suppresses hyperacute rejection of pig to baboon renal xenografts
- PMID: 11014647
- DOI: 10.1097/00007890-200009270-00011
Specific depletion of preformed IgM natural antibodies by administration of anti-mu monoclonal antibody suppresses hyperacute rejection of pig to baboon renal xenografts
Abstract
Background: The elimination of circulating anti-porcine preformed antibodies is crucial for avoiding hyperacute vascular rejection (HAVR) of primarily vascularized xenograft in discordant pig to baboon model. Previously described methods used for eliminating natural antibodies, however, constantly removed both anti-porcine IgM and IgG antibodies, as well as often complement proteins. To study specifically the role of preformed anti-porcine IgM antibodies, a specific anti-IgM monoclonal antibody (mAb) has been designed and evaluated in vivo.
Methods: Iterative injections of anti-IgM mAb (LO-BM2) at high dose (20 mg/kg) depleted to undetectable level the circulating IgM and therefore anti-porcine IgM antibodies but did not change the concentration of anti-pig IgG antibodies. The serum concentration of IgM and IgG antibodies was assessed by ELISA and the level of anti-pig natural IgM and IgG antibodies by flow cytometry (FC). Anti-rat sensitization was assessed by specific ELISA as well as the serum concentration of LO-BM2.
Results: Iterative injections of LO-BM2 allowed to specifically eliminate the anti-porcine IgM antibodies to undetectable levels at ELISA. Despite a normal serum level of anti-porcine IgG and complement proteins, HAVR was avoided. Without immunosuppression, the specific elimination of preformed anti-porcine IgM prolonged the survival of a renal xenograft in baboon up to 6 days, whereas without IgM antibody elimination, the renal xenografts were hyperacutely rejected within hours. The lost of activity of LO-BM2 after 10 days was concomitant to an IgM and IgG antibody rebound, which caused an acute vascular rejection of the xenograft.
Conclusion: Specific elimination of natural anti-porcine IgM antibodies allows to avoid HAVR of a pig to baboon renal xenograft, whereas anti-porcine IgG antibodies and complement proteins were present in the serum. This result confirms previous in vitro reports and demonstrates for the first time in vivo that preformed IgM antibodies alone are responsible for HAVR, while preformed anti-porcine IgG antibodies are unable alone to cause HAVR. Anti-IgM therapy appears as an important tool to transiently but completely eliminates xeno-IgM antibodies in vivo.
Similar articles
-
Characterization of baboon anti-porcine IgG antibodies during acute vascular rejection of porcine kidney xenograft.Xenotransplantation. 2002 Sep;9(5):338-49. doi: 10.1034/j.1399-3089.2002.01090.x. Xenotransplantation. 2002. PMID: 12199865
-
In vivo IgM depletion by anti-mu monoclonal antibody therapy. The role of IgM in hyperacute vascular rejection of discordant xenografts.Transplantation. 1994 Apr 15;57(7):1003-9. Transplantation. 1994. PMID: 8165695
-
Depletion of IgM xenoreactive natural antibodies by injection of anti-mu monoclonal antibodies.Immunol Rev. 1994 Oct;141:95-125. doi: 10.1111/j.1600-065x.1994.tb00874.x. Immunol Rev. 1994. PMID: 7868159 Review.
-
Prolongation of cardiac xenograft survival by depletion of complement.Transplantation. 1993 Apr;55(4):857-65; discussion 865-6. doi: 10.1097/00007890-199304000-00033. Transplantation. 1993. PMID: 8475561
-
[Attempt at preventing hyperacute xenogenic rejection by isotopic suppression of IgM in the recipient].Ann Chir. 1996;50(7):524-31. Ann Chir. 1996. PMID: 9035421 Review. French.
Cited by
-
In vivo deglycosylation of recombinant glycoproteins in tobacco BY-2 cells.Plant Biotechnol J. 2023 Sep;21(9):1773-1784. doi: 10.1111/pbi.14074. Epub 2023 Jun 2. Plant Biotechnol J. 2023. PMID: 37266972 Free PMC article.
-
Different subcellular localization and glycosylation for a functional antibody expressed in Nicotiana tabacum plants and suspension cells.Transgenic Res. 2009 Jun;18(3):467-82. doi: 10.1007/s11248-008-9240-1. Epub 2009 Jan 14. Transgenic Res. 2009. PMID: 19140023
-
Identification of an anti-idiotypic antibody that defines a B-cell subset(s) producing xenoantibodies in primates.Immunology. 2008 Mar;123(3):390-7. doi: 10.1111/j.1365-2567.2007.02704.x. Epub 2007 Oct 3. Immunology. 2008. PMID: 17916162 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials